That's Good Science!^™ | videos

What if your own immune cells could fight off cancer? That's the idea behind cancer immunotherapy. Dr. Steven Rosenberg's group at the National Cancer Institute introduces T-cell receptor genes recognizing specific cancer antigens into a patient's own lymphocytes. RetroNectin® reagent is used in creation of these modified lymphocytes. These engineered cells are then returned to the patient where they specifically target cancer cells expressing the antigen. That's Good Science!™

learn about featured products >>